Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Delivra Health Brands Inc. is a Canada-based company, which provides lifestyle, and health and wellness products to consumers and patients in regulated markets around the world. The Company's subsidiaries include Dream Water Global (Dream Water) and Delivra Corp. (Delivra). The Company’s portfolio features brands like Dream Water and LivRelief. Its Dream Water brand offers sleep aids in a range of formats and formulations. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions, such as joint and muscle pain, nerve pain, varicose veins, wound healing and sports performance.


TSXV:DHB - Post by User

Bullboard Posts
Post by Toptenconceptson Jun 05, 2019 10:30pm
198 Views
Post# 29801630

Satipharm to drive revenue before infusion

Satipharm to drive revenue before infusion
Colins presentations for Q3 Basically infused products wont hit th shelfs till 2020 ...they see the pills making money this year .. also he said he thought dreamwater will bring 10 million in the next 12 months and dva will also bring in 8 so if satipharm can get going ..and the weed could do 12 million in the next 12 months things r looking up .. satipharm numbers will be interesting in q4 .. not happy but lets see if sell some pills .. the fact that the ganja build up is delayed to end of year does not bother me .. lets the numbers in q4 hoping for 6 million .. but satipharm numbers are key ..
Bullboard Posts